India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir

The approval process for remdesivir was accelerated in view of the emergency situation and the unmet need for medicines in light of the coronavirus outbreak, a source in the know of the developments told .

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gN3lio
via IFTTT